Medicared For All Logo

Ganesh Akula in Orlando, Florida

Home Florida Orlando

Ganesh Akula has Pulmonary Disease as his primary medical specialty. Their primary office is: 930 S Orange Ave in Orlando, Florida. They attended Sorry, his university is not listed and graduated in 1979 (around 45 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ganesh K Akula Office Phone and Directions

Ganesh Akula
930 S Orange Ave
Orlando, Florida 32806
407-425-3362

Patient Ratings
Please rate your experience with Ganesh Akula below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 407-425-3362


Enter a starting address:


Healthcare Info for Ganesh Akula

Medical School: Sorry, his university is not listed
Graduation Year: 1979
The Primary Medical Specialty for Ganesh Akula is listed as: Pulmonary Disease
Approximate Years of Experience: 45
PAC (PECOS ID)#: 3476728585
NPI #: 1154358109
NPI Created On: 06/26/2006
NPI Last Updated Listed as: 02/18/2010
Primary Taxonomy Code: 207RP1001X
License Number:
60461
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Celtic Insurance Company
  • Blue Cross Blue Shield
  • Oscar Insurance Company of Florida
  • Medicare

They are listed as accepting new patients in some locations.

Languages spoken by staff include: English, Telugu, Spanish, Hindi.

Services and Procedures include:

  1. Irrigation and suction of lung airways to obtain cells using an endoscope
  2. Removal of fluid from chest cavity with insertion of indwelling catheter, accessed through the skin
  3. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  4. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  5. Determination of lung volumes using gas dilution or washout
  6. Determination of lung volumes using gas dilution or washout
  7. Measurement of lung diffusing capacity
  8. Measurement of lung diffusing capacity
  9. New patient office or other outpatient visit, typically 45 minutes
  10. Established patient office or other outpatient visit, typically 15 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Initial hospital inpatient care, typically 50 minutes per day
  13. Initial hospital inpatient care, typically 70 minutes per day
  14. Subsequent hospital inpatient care, typically 25 minutes per day
  15. Subsequent hospital inpatient care, typically 35 minutes per day
  16. Critical care delivery critically ill or injured patient, first 30-74 minutes
  17. Initial nursing facility visit, typically 35 minutes per day
  18. Subsequent nursing facility visit, typically 15 minutes per day
  19. Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787930737

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787930739

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787930741

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801651393

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802080203

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802522339

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802712303

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802729753

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802739045

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802865917

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Pulmonary Disease Professionals in Orlando

1.
Chirin Orabi

1414 Kuhl Ave
Orlando, FL
Orlando Health Medical Group Inc

2.
Guillermo Garrido Rosa

1222 S Orange Ave
Orlando, FL
Orlando Health Medical Group Inc

3.
Maria Katrina Abril

601 E Rollins St
Orlando, FL
Florida Hospital Medical Group Inc

4.
Maria Katrina Abril

2501 N Orange Ave
Orlando, FL
Florida Hospital Medical Group Inc

5.
Luis Faverio

60 W Gore St
Orlando, FL
Orlando Health Medical Group Inc

6.
Albert Magh

9430 Turkey Lake Rd
Orlando, FL
Orlando Health Medical Group Inc

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry


Medicared For All
Vote!
Share